ROCKET PHARMACEUTICALS, INC. short interest in 2024
In 2024, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 9.15% of shares outstanding on 12 Jan 2024 to 14.18% on 31 Dec 2024, a change of +5.03 percentage points. The year's high was 14.18% on 31 Dec 2024 and its low 9.15% on 12 Jan 2024, averaging 11.40% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.71 days on 13 Sep 2024. Full history: ROCKET PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 9.15% (12 Jan 2024)
- End of year
- 14.18% (31 Dec 2024)
- Change
- +5.03 pp
- High
- 14.18% (31 Dec 2024)
- Low
- 9.15% (12 Jan 2024)
- Average
- 11.40%
- Highest days to cover
- 19.71 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 9.15% | 12.27 | |
| 31 Jan 2024 | 9.37% | 12.65 | |
| 15 Feb 2024 | 10.20% | 12.58 | |
| 29 Feb 2024 | 11.05% | 12.16 | results (8-K), 10-K filed |
| 15 Mar 2024 | 11.36% | 11.79 | |
| 28 Mar 2024 | 11.67% | 18.84 | |
| 15 Apr 2024 | 12.21% | 17.52 | |
| 30 Apr 2024 | 10.91% | 13.06 | |
| 15 May 2024 | 11.01% | 19.46 | results (8-K), 10-Q filed |
| 31 May 2024 | 10.37% | 14.10 | |
| 14 Jun 2024 | 10.20% | 14.50 | |
| 28 Jun 2024 | 9.26% | 5.40 | |
| 15 Jul 2024 | 10.62% | 14.11 | |
| 31 Jul 2024 | 11.60% | 15.10 | |
| 15 Aug 2024 | 12.01% | 13.15 | results (8-K), 10-Q filed |
| 30 Aug 2024 | 12.01% | 16.16 | |
| 13 Sep 2024 | 12.38% | 19.71 | |
| 30 Sep 2024 | 12.53% | 8.73 | |
| 15 Oct 2024 | 12.66% | 11.84 | |
| 31 Oct 2024 | 13.08% | 19.14 | |
| 15 Nov 2024 | 12.17% | 12.90 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 11.39% | 9.05 | |
| 13 Dec 2024 | 12.26% | 7.95 | |
| 31 Dec 2024 | 14.18% | 7.46 |
See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.